ScienceDaily (June 14, 2010) — There is a new path to defeat systemic sclerosis, also called scleroderma because of the hardening of the skin of the patients (from Greek skleros, “hard,” and derma, “skin”). This path involves the B-cell of the immune system, so far only considered “innocent spectators,” as Catholic University rheumatologist Gianfranco Ferraccioli, among the authors of this research, puts it.
